Search

everythinglearnresearchcommunity

for

Search:↓

Combined BRAF and MEK treatment increases rash risk but reduces other skin issues compared to BRAF alone.

Stopping mitochondrial respiration can prevent brain cancer spread in skin cancer patients, and plant compound β-sitosterol could help achieve this.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

A topical BRAF inhibitor, vemurafenib, can speed up wound healing and promote hair growth, especially in diabetic patients.

A protein called IL-36γ causes skin side effects from certain cancer treatments when combined with a common skin bacteria.

Blocking RANK signaling might help treat metastatic melanoma, but more research is needed.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

Melanoma's complexity requires personalized treatments due to key genetic mutations and tumor-initiating cells.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

New treatments and management strategies for skin conditions like melanoma and Spitz naevi were discussed at the dermatologists' meeting.

The model and estimator can predict drug exposure in kidney transplant patients well.

Patients on dabrafenib and trametinib for melanoma often experience skin side effects.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Many men with androgenic alopecia also have dyslipidemia.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

A group has developed therapies that show promise for treating cancer and various other conditions.

The document concludes that understanding and managing hair loss in cancer patients is important, and more research is needed for better treatments.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.